ChatBot Beta

Biome Australia Limited

BIO

AU0000184137

Pharmaceuticals

Delayed Australian S.E. Other stock markets 08:02:42 2025-02-11 pm EST			5-day change	1st Jan Change
0.6100 ^AUD	+1.67%		-1.61%	+3.39%

Feb. 04	Biome Australia Signs Co-Investment Deal for IP Development; Shares Up 5%	MT
Jan. 30	Biome Australia Reports Positive Results from Clinical Development of Probiotic Strain	MT

Biome Australia Limited Reports Unaudited Revenue Results for the Second Quarter and Half Year of 2024

January 01, 2024 at 04:25 pm EST

Biome Australia Limited reported unaudited revenue results for the second quarter and half year of 2024. For the quarter, the company reported sales revenue of ~$3.3 million.

For the half year, the company reported sales revenue of ~$6 million.

Latest news about Biome Australia Limited

Biome Australia Signs Co-Investment Deal for IP Development; Shares Up 5%	Feb. 04	MT
Biome Australia Reports Positive Results from Clinical Development of Probiotic Strain	Jan. 30	MT
Biome Australia Expands Australian Distribution Network	Jan. 23	MT
Biome Australia Posts Higher Fiscal Q2 Sales Revenue; Shares Down 4%	Jan. 05	MT
Biome Australia Limited Provides Revenue Guidance for Second Quarter of Fiscal Year 2025	Nov. 26	CI
Biome Australia Limited Appoints Geoffrey Sam Oam as Non-Executive Director	Nov. 20	CI
Biome Australia's Fiscal Q1 Revenue Climbs 55%, Exceeds Target; Shares Up 4%	24-09-30	MT
Biome Australia Limited Reports Unaudited Sales Results for the First Quarter of Fiscal Year 2025	24-09-30	CI
Biome Australia Signs Distribution Deal with Ecotrend Ecologics in Canada; Shares Up 5%	24-09-18	MT
Biome Australia Limited Provides Earnings Guidance for the First Quarter of Fiscal Year 2025	24-09-02	CI
Biome Australia Limited Reports Earnings Results for the Full Year Ended June 30, 2024	24-08-25	CI
Biome Australia Launches Cholesterol Lowering Probiotic Product	24-08-19	MT
Biome Australia Sets Higher Three-Year Revenue Target; Shares Jump 9%	24-07-28	MT
Biome Australia Issues 300,000 Shares Upon Exercise of Options; Shares Up 10%	24-07-05	MT
Biome Australia Reaches Record Revenue in H2 FY24, Tops Full-Year Upgraded Guidance	24-06-30	MT
Biome Australia Limited Reports Unaudited Revenue Results for the Fourth Quarter, Second Half and Full Year 2024	24-06-30	CI
Biome Australia to Exceed Upgraded Fiscal 2024 Revenue Guidance; Shares Jump 15%	24-06-12	MT
Biome Australia Anticipates International Sales Revenue to Grow 85% in Fiscal 2024; Shares Down 4%	24-05-29	MT
Biome Australia Logs 74% Revenue Increase in Fiscal Q3	24-04-10	MT
Biome Australia Logs First Positive Underlying Quarterly Cash Flow in Fiscal Q3	24-04-02	MT
Europe opens higher ahead of further US indicators	24-03-14	RE
Biome Australia Limited Reports Earnings Results for the Half Year Ended December 31, 2023	24-02-21	CI
Biome's Activated Probiotics Enters UK, Ireland; Shares Jump 10%	24-01-14	MT
Biome Australia Raises Fiscal 2024 Revenue Guidance	24-01-08	MT
Microbiome Health Company Biome Australia Limited Revises Earnings Guidance for 2024	24-01-07	CI

Chart Biome Australia Limited

Duration

Period

BIO: Dynamic Chart

Company Profile

Biome Australia Ltd is an Australia-based microbiome health company. The Company develops, licenses, commercializes and markets evidence-based live biotherapeutics (probiotics) and complementary medicines. It develops, manufactures, and distributes evidence-based products linking the gut and human health through the Company owned brands, such as Activated Nutrients and Activated Probiotics. Activated Nutrients offers a range of completely organic, plant-based, all in-one nutritional products. Activated Probiotics offers a range of clinically backed precision probiotics. Activated Probiotics provides live biotherapeutic products clinically proven to help prevent and support the management of various health concerns, including low mood and sleep, bone health, iron malabsorption, mild eczema through randomized double-blind placebo-controlled trials. Activated Probiotics products include Biome Acne Probiotic, Biome Baby Probiotic, Biome Eczema Probiotic, and Biome Acne Probiotic.

Employees

Sector

Pharmaceuticals

Calendar

2025-03-02 - Q2 2025 Earnings Release (Projected)

More about the company